388 related articles for article (PubMed ID: 25162470)
1. Determining whether excision of all fibroepithelial lesions of the breast is needed to exclude phyllodes tumor: upgrade rate of fibroepithelial lesions of the breast to phyllodes tumor.
Van Osdol AD; Landercasper J; Andersen JJ; Ellis RL; Gensch EM; Johnson JM; De Maiffe B; Marcou KA; Al-Hamadani M; Vang CA
JAMA Surg; 2014 Oct; 149(10):1081-5. PubMed ID: 25162470
[TBL] [Abstract][Full Text] [Related]
2. Fibroepithelial breast lesions diagnosed by core needle biopsy demonstrate a moderate rate of upstaging to phyllodes tumors.
Marcil G; Wong S; Trabulsi N; Allard-Coutu A; Parsyan A; Omeroglu A; Atinel G; Mesurolle B; Meterissian S
Am J Surg; 2017 Aug; 214(2):318-322. PubMed ID: 28057293
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with phyllodes tumor of the breast after core needle biopsy identifies fibroepithelial neoplasm.
Gould DJ; Salmans JA; Lassinger BK; Contreras A; Gutierrez C; Bonefas E; Liscum KR; Silberfein EJ
J Surg Res; 2012 Nov; 178(1):299-303. PubMed ID: 22524977
[TBL] [Abstract][Full Text] [Related]
4. Clinical and radiologic data and core needle biopsy findings should dictate management of cellular fibroepithelial tumors of the breast.
Resetkova E; Khazai L; Albarracin CT; Arribas E
Breast J; 2010; 16(6):573-80. PubMed ID: 21070433
[TBL] [Abstract][Full Text] [Related]
5. Core needle biopsy as a diagnostic tool to differentiate phyllodes tumor from fibroadenoma.
Komenaka IK; El-Tamer M; Pile-Spellman E; Hibshoosh H
Arch Surg; 2003 Sep; 138(9):987-90. PubMed ID: 12963656
[TBL] [Abstract][Full Text] [Related]
6. Fibroepithelial lesions with cellular stroma on breast core needle biopsy: are there predictors of outcome on surgical excision?
Jacobs TW; Chen YY; Guinee DG; Holden JA; Cha I; Bauermeister DE; Hashimoto B; Wolverton D; Hartzog G
Am J Clin Pathol; 2005 Sep; 124(3):342-54. PubMed ID: 16191502
[TBL] [Abstract][Full Text] [Related]
7. Interobserver variation in the diagnosis of fibroepithelial lesions of the breast: a multicentre audit by digital pathology.
Dessauvagie BF; Lee AHS; Meehan K; Nijhawan A; Tan PH; Thomas J; Tie B; Treanor D; Umar S; Hanby AM; Millican-Slater R
J Clin Pathol; 2018 Aug; 71(8):672-679. PubMed ID: 29440134
[TBL] [Abstract][Full Text] [Related]
8. Excision of breast fibroepithelial lesions: when is it still necessary?-A 10-year review of a regional centre.
Mousa-Doust D; Dingee CK; Chen L; Bazzarelli A; Kuusk U; Pao JS; Warburton R; McKevitt EC
Breast Cancer Res Treat; 2022 Jul; 194(2):307-314. PubMed ID: 35639263
[TBL] [Abstract][Full Text] [Related]
9. Fibroepithelial Lesions (FELs) of the Breast: Is Routine Excision Always Necessary?
Limberg J; Barker K; Hoda S; Simmons R; Michaels A; Marti JL
World J Surg; 2020 May; 44(5):1552-1558. PubMed ID: 31974650
[TBL] [Abstract][Full Text] [Related]
10. Fibroadenoma versus phyllodes tumor: distinguishing factors in patients diagnosed with fibroepithelial lesions after a core needle biopsy.
Wiratkapun C; Piyapan P; Lertsithichai P; Larbcharoensub N
Diagn Interv Radiol; 2014; 20(1):27-33. PubMed ID: 24356293
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of histological features between core needle biopsy and surgical excision in phyllodes tumor.
Choi J; Koo JS
Pathol Int; 2012 Feb; 62(2):120-6. PubMed ID: 22243782
[TBL] [Abstract][Full Text] [Related]
12. Which lesions with a radiological or core biopsy diagnosis of fibroadenoma should be excised?
Lee A; James J; Whisker L; Rakha EA; Ellis IO
Ann R Coll Surg Engl; 2022 May; 104(5):361-366. PubMed ID: 34939848
[TBL] [Abstract][Full Text] [Related]
13. Malignant transformation of breast fibroadenoma to malignant phyllodes tumor: long-term outcome of 36 malignant phyllodes tumors.
Abe M; Miyata S; Nishimura S; Iijima K; Makita M; Akiyama F; Iwase T
Breast Cancer; 2011 Oct; 18(4):268-72. PubMed ID: 22121516
[TBL] [Abstract][Full Text] [Related]
14. Phyllodes tumours of the breast diagnosed as B3 category on image-guided 14-gauge core biopsy: analysis of 51 cases from a single institution and review of the literature.
Abdulcadir D; Nori J; Meattini I; Giannotti E; Boeri C; Vanzi E; Vezzosi V; Bianchi S
Eur J Surg Oncol; 2014 Jul; 40(7):859-64. PubMed ID: 24612651
[TBL] [Abstract][Full Text] [Related]
15. Ultrasonography and core needle biopsy in the differential diagnosis of fibroadenoma and tumor phyllodes.
Bode MK; Rissanen T; Apaja-Sarkkinen M
Acta Radiol; 2007 Sep; 48(7):708-13. PubMed ID: 17728999
[TBL] [Abstract][Full Text] [Related]
16. Development of a Management Algorithm for the Diagnosis of Cellular Fibroepithelial Lesions From Core Needle Biopsies.
Jung J; Kang E; Chae SM; Kim H; Park SY; Yun B; Kim SM; Jang M; Kim SW; Kim EK
Int J Surg Pathol; 2018 Dec; 26(8):684-692. PubMed ID: 29774785
[TBL] [Abstract][Full Text] [Related]
17. Analysis of histological features in needle core biopsy of breast useful in preoperative distinction between fibroadenoma and phyllodes tumour.
Morgan JM; Douglas-Jones AG; Gupta SK
Histopathology; 2010 Mar; 56(4):489-500. PubMed ID: 20459556
[TBL] [Abstract][Full Text] [Related]
18. Upstaging of Fibroepithelial Lesions: A Single-Institution Experience.
Mohan SC; Tseng J; Marumoto A; Angarita S; Dadmanesh F; Amersi F; Giuliano A; Chung A
Ann Surg Oncol; 2022 Apr; 29(4):2193-2199. PubMed ID: 34671884
[TBL] [Abstract][Full Text] [Related]
19. Fibroepithelial lesions; The WHO spectrum.
Krings G; Bean GR; Chen YY
Semin Diagn Pathol; 2017 Sep; 34(5):438-452. PubMed ID: 28688536
[TBL] [Abstract][Full Text] [Related]
20. A study of fibroepithelial tumours of the breast.
Badhe BA; Iyengar KR; Alva N
Indian J Cancer; 2002; 39(3):91-6. PubMed ID: 12928563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
